|
Congress has reached an important milestone in the Fiscal Year 2027 funding process, with the House completing work on its annual appropriations bills and the Senate expected to begin its own negotiations soon. While the House proposals include increased investments in medical research, they also recommend significant reductions to several public health programs, setting the stage for continued debate over funding priorities in the months ahead.
At the same time, policymakers continue to consider a range of issues that could affect patients and families, including updates to the 340B Drug Pricing Program, Essential Health Benefits, Medicaid work requirements, and patient access protections such as copay accumulators, step therapy, and prior authorization. As these discussions evolve, advocacy will remain critical in ensuring patient perspectives help shape future healthcare policy.
To help you stay informed, we've also published several new blogs covering the latest advocacy efforts, policy developments, and healthcare news you need to know. I encourage you to explore these resources and visit our Advocacy Action Center to learn how you can share your story and support policies that improve access to care.
The months ahead will bring important decisions that could influence the future of research funding, patient protections, and access to care. We remain committed to keeping you informed every step of the way and providing opportunities to learn, engage, and take action when your voice can make a difference.
|